YOLFTbeta
Exicure Inc

Exicure Inc

XCUR · NASDAQ · Healthcare / Biotechnology

1.08USD+0.02 (+1.89%)

Price History

Full chart

Market Stats

Previous Close1.06
Open1.02
Day Range1.02 – 1.08
52-Week Range1.05 – 9.48
Volume6.47K
Market Cap7.79M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.31
Dividend Yield0.00%
Beta3.62
50-Day Avg1.39
200-Day Avg3.27

About

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jungsoo Kim
  • Employees1
  • Headquarters400 Seaport Court, Redwood City, CA, United States, 94063, USA
  • Websitehttps://www.exicuretx.com

Leadership

  • Mr. Jungsoo KimCEO, President & Director · b. 1973
  • Mr. Gyuyeob LeeInterim CFO & Secretary · b. 1986
  • Mr. Young Seung KoChief Operating Officer · b. 1976
  • Mr. Joshua MillerChief Accounting Officer · b. 1977
  • Dr. Devki Sukhtankar Ph.D.Head of Preclinical Research & Translational Medicine
  • Dr. Niña Caculitan Ph.D.Head of Clinical

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.39M1.04M9.72M118.00K1.30M16.61M-483.00K28.83M0500.00K0
Growth (%)--56.62%+838.13%-98.79%+998.31%+1181.87%-102.91%+6068.12%-100.00%--100.00%
Cost of Revenue10.12M13.66M13.08M14.12M14.12M32.09M1.78M1.86M1.42M824.00K460.00K
Gross Profit-7.74M-12.62M-3.36M118.00K1.30M-15.48M-483.00K26.97M-1.42M500.00K-460.00K
Gross Margin-323.95%-1218.44%-34.58%100.00%100.00%-93.19%100.00%93.56%-100.00%-
Operating Expense5.41M3.54M7.05M21.94M27.91M9.96M62.07M28.80M13.57M12.73M9.66M
Operating Income-13.14M-16.16M-10.41M-21.82M-26.62M-25.44M-62.55M-1.83M-15.00M-12.23M-10.12M
Operating Margin-550.42%-1560.04%-107.08%-18490.68%-2053.78%-153.11%12950.10%-6.35%--2446.40%-
EBITDA-13.02M-16.04M-9.98M-21.71M-24.79M-22.65M-60.63M78.00K-15.54M-8.85M-5.12M
EBITDA Margin-545.14%-1547.97%-102.73%-18394.92%-1913.04%-136.33%12553.21%0.27%--1770.20%-
Net Income-13.15M-16.94M-11.01M-22.41M-26.30M-24.67M-64.10M-2.58M-16.91M-9.70M-4.95M
Net Income Margin-550.71%-1635.23%-113.29%-18994.07%-2029.55%-148.49%13271.64%-8.96%--1940.20%-
R&D10.12M13.66M13.08M14.12M19.34M32.09M48.98M19.77M1.42M03.29M
R&D as % of Total Revenue423.95%1318.44%134.58%11965.25%1492.28%193.19%-10140.58%68.57%-0.00%-
Interest Expense0724.00K795.00K672.00K786.00K573.00K1.69M595.00K018.00K1.00K
Interest Expense % of Total Revenue0.00%69.88%8.18%569.49%60.65%3.45%-350.10%2.06%-3.60%-

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets19.62M20.58M28.99M28.76M115.26M100.44M64.87M23.33M11.58M15.06M14.04M
Total Liabilities1.39M18.13M9.01M7.80M34.52M38.94M53.64M8.41M8.55M8.28M10.12M
Total Equity18.23M2.45M19.98M20.95M80.75M61.51M11.23M14.92M3.03M6.77M3.93M
Cash18.73M19.62M25.76M26.27M48.46M33.26M34.64M8.58M816.00K12.51M3.75M
Total Debt-5.87M4.86M4.92M5.32M24.77M14.74M7.31M6.67M5.93M176.00K
Net Debt-18.73M-13.96M-20.91M-21.34M-43.14M-8.49M-19.91M-1.27M5.85M-6.57M-3.57M

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-12.20M-5.05M-19.79M-19.49M1.32M-39.27M-34.82M-35.66M-10.36M-2.91M-8.55M
Investing Cash Flow-12.00K-394.00K-926.00K-94.00K-63.43M10.14M43.09M4.70M-1.08M--1.81M
Financing Cash Flow19.61M6.34M26.86M20.09M84.31M15.13M1.12M-3.10M3.67M13.40M1.60M
Capital Expenditure12.00K394.00K926.00K94.00K1.08M3.17M968.00K10.00K001.00K
Free Cash Flow-12.21M-5.44M-20.71M-19.58M235.00K-42.44M-35.79M-35.67M-10.36M-2.91M-8.56M
FCF to OCF100.10%107.80%104.68%100.48%17.84%108.07%102.78%100.03%100.00%100.00%100.01%

Earnings

Report DateMay 15, 2018Aug 6, 2018Nov 6, 2018Mar 8, 2019May 8, 2019Aug 8, 2019Nov 7, 2019Mar 3, 2020May 14, 2020Aug 12, 2020Nov 12, 2020Mar 11, 2021May 12, 2021Aug 12, 2021Nov 19, 2021Mar 25, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 27, 2023Aug 11, 2023Nov 16, 2023Mar 7, 2024Jun 17, 2024Aug 13, 2024Nov 15, 2024Mar 20, 2025Jun 4, 2025Aug 8, 2025Nov 7, 2025Aug 14, 2026Nov 6, 2026
EPS Estimate--22.50-24.00-4.50-18.00-19.50-12.00-2.62-13.50-12.75-13.88-3.12-16.50-19.50-22.50-4.20-10.50-6.00-0.90-0.19-0.00-0.00-----0.00--
EPS Actual-0.14-25.50-19.50-3.00-18.00-18.00-13.50-3.901.50-7.50-15.00-4.20-21.00-24.00-40.50-4.50-10.50-8.30-1.044.10-0.70-0.61-0.17-0.61-0.07-0.57-1.190.49-0.41-0.39-0.18-
Surprise--13.33%18.75%33.33%0.00%7.69%-12.50%-48.85%111.11%41.18%-8.07%-34.62%-27.27%-23.08%-80.00%-7.14%0.00%-38.33%-15.56%2257.89%------------
TimingAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--After-hoursAfter-hours--After-hours----

Key Statistics & Ratios

Market Cap7.79M
Enterprise Value5.67M
Trailing P/E0.00
Forward P/E0.00
Price / Sales13.61
Price / Book8.44
EPS-1.31
Book Value0.329
Revenue (TTM)0
Gross Profit (TTM)1.26M
EBITDA-7.11M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-168.37%
Return on Assets-30.32%
Shares Outstanding6.55M
Shares Float3.10M
Beta3.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 2.00
  • Strong Buy
    2
  • Buy
    2

Ownership Breakdown

Institutions
2.25%
Insiders
41.47%
Retail / Other
56.28%

Top Institutional Holders

  • Geode Capital Management, LLC
    36.91K0.56%
  • Vanguard Capital Management, LLC
    32.98K0.50%
  • Citadel Advisors Llc
    14.92K0.23%
  • Vanguard Fiduciary Trust Co
    13.16K0.20%
  • Northern Trust Corp
    10.69K0.16%
  • BlackRock Inc
    9.35K0.14%
  • UBS Group AG
    8660.01%
  • Tower Research Capital LLC
    4890.01%
  • Morgan Stanley - Brokerage Accounts
    1580.00%
  • Fortitude Family Office LLC
    1200.00%
  • Efficient Wealth Management LLC
    1200.00%
  • SBI Securities Co Ltd
    430.00%
  • Advisor Group Holdings, Inc.
    290.00%
  • Prestige Wealth Management Group LLC
    200.00%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    14.23K0.22%
  • Fidelity Extended Market Index
    12.76K0.19%
  • Fidelity Nasdaq Composite Index
    5.37K0.08%
  • Fidelity Total Market Index
    4.73K0.07%
  • Fidelity Series Total Market Index
    3.64K0.06%
  • BlackRock Diversified Equity Alpha Inst
    350.00%

Stock Splits

  • Aug 28, 20241:5
  • Jun 30, 20221:30